# Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not

> **NCT00688532** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5103 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00688532
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 5103 (ACTUAL)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688532, "Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00688532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*